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cohort of patients, we examined abdominal symptom frequency, initial diagnostic
suspicion, and actions of GPs in response to abdominal symptoms.
Methods: Over a 10-day period, 493 GPs in Norway, Denmark, Sweden, Belgium,
the Netherlands, and Scotland, recorded consecutive consultations: sex, date of
birth and any specified abdominal symptoms. For patients with abdominal
symptoms, additional data on non-specific symptoms, GPs’ diagnostic suspicion,
and features of the consultation were noted. Data on all cancer diagnoses among all
included patients were requested from the GPs eight months later.
Findings: Consultations with 61802 patients were recorded. Abdominal symptoms
were recorded in 6264 (10.1%) patients. A subsequent malignancy was reported in
511 patients (0.8%): 441 (86.3%) had a new cancer, 70 (13.7%) a recurrent cancer.
Abdominal symptoms were noted in 129 (25.2%) of cancer patients (P < 0.001),
rising to 34.5% for the 89 patients with cancer located in the abdominal region.
PPV for any cancer given any abdominal symptom was 2.1%.
In symptomatic patients diagnosed with cancer, GPs noted a suspicion of cancer
for 85 (65.9%) versus 1895 (30.9%) when there was no subsequent cancer (P <
0.001). No suspicion was noted in 32 (24.8%) cancer patients. The GP’s intuitive
cancer suspicion was independently associated with a subsequent new cancer
diagnosis (OR 2.11, 95% CI 1.15–3.89).
Laboratory tests were ordered for 45.4% of symptomatic patients, imaging for
10.4%, referral or hospitalization for 20.0%: all were more frequent in subsequent
cancer patients (P < 0.001).
Interpretation: Abdominal symptoms pointed to abdominal cancers rather than to
other cancers. However, the finding of abdominal symptoms in only one third of
patients with an abdominal cancer, and the lack of cancer suspicion in a quarter of
symptomatic cancer patients, provide challenges for GPs’ diagnostic thinking and
referral practices.
Keywords: Medicine, Evidence-based medicine, Public health, Oncology
1. Introduction
The medical concept of alarm symptoms or warning signs of cancer (WSC) goes
back to the 1940s [1]. Originally developed to inform the public about what to tell
their doctors in order to avoid delayed cancer diagnoses, they did not distinguish
between populations at higher or lower risk. In general practice, symptoms are
frequent and cancers comparatively rare. General practitioners (GPs) take an active
part in the diagnostic process of 80–90% of cancer patients [2, 3, 4]. The GP’s
challenge is to identify patients who potentially have cancer, in order to make
expedient referrals to more specialised investigations and care. In recent years,
much primary care research has explored the significance of various symptoms in
early cancer diagnosis [5, 6].
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About half of all cancers are in some way related to the abdomen [7]. We
undertook an international collaborative prospective cohort study in six northern
European countries in 2011–2012, in order to explore the role of specified
abdominal symptoms presented to GPs, in relation to suspecting cancer.
In this paper we analyse the frequency of abdominal symptoms in primary care in
our cohort, and what patients’ GPs thought and did in response to these symptoms,




The study was undertaken in primary care practices in Norway, Denmark, Sweden,
Netherlands, Belgium, and Scotland. GPs in these countries have broadly similar
medical training and approaches to cancer diagnosis, treatment, and referral,
although their gatekeeper role, laboratory facilities in the surgery, and access to
GP-requested imaging vary moderately between and within countries [8].
Participating GPs were recruited through academic institutions active in The
Cancer and Primary Care Research International Network (Ca-PRI) [9]. In the six
countries, 588 GPs were invited to participate: in one country from a sentinel
network [10], otherwise more or less randomly. GPs received 100€ for initial
participation, and 50€ for completing follow-up registrations.
2.2. Initial registrations (Time 1)
Between 25 February 2011 and 27 July 2011, the GPs registered all consecutive
consultations with patients 16 years of age and older, over ten working days. Data
were collected through a study questionnaire (Appendix A) which required
completion for each patient and which was modified from a previous symptom
study [5] and pilot tested before distribution. GPs received a desktop workbook
containing daily registration forms: the forms were prepared in different languages,
with professional two-way translation from the English original.
The GPs recorded sex and date of birth for all patients, and abdominal symptoms if
presented during the consultation. If abdominal symptoms were recorded, the GP
completed all remaining fields, including the recording of more general, non-
specific symptoms selected from medical literature related to cancer. The GPs
noted duration of symptoms, diagnostic action taken by the GP, the degree of
cancer suspicion, if any, based on symptoms, clinical findings, and intuition, and
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2.3. Follow up (Time 2)
Participating GPs had consented to providing data on all cancer diagnoses (new or
recurring) in their practice. Eight months after the initial registration period, each
GP was asked to report all such patients on a standardized proforma. GPs used
their electronic records to supply anonymised information about the patients
diagnosed with cancer during the follow-up period, regardless of whether they had
presented symptoms during the initial survey. We linked sex, date of birth, GP
number and date of consultation to the patients registered during the initial 10-days
registration. GPs received two reminders.
2.4. Data logistics and management
Completed forms were optically read. Each form was manually checked for
clarification of unclear or illogical recordings. Free-text comments were recorded
manually.
For patients with more than one consultation within the ten day period, the last
consultation was used as date of consultation. Symptoms recorded during different
consultations were all included, with the longest duration noted.
We distinguished between abdominal and non-abdominal cancers. Included in the
abdominal group were: a. Cancers primarily located in the abdomen, i.e. cancers of
digestive organs below the pharynx, female genital organs above the vulva, and
urinary organs including testis. b. Carcinoids, lymphomas, soft tissue cancers,
endocrine tumours, and generalised cancer if, according to the GP’s description,
they showed some kind of neoplastic manifestation in the abdomen, and extra-
abdominal types of cancer if initial manifestations were abdominal. All remaining
cancers were classed as non-abdominal.
Classification as a recurrent cancer required a period of apparent remission before
the time of consultation.
2.5. Sample size calculations
A pilot study and incidence data suggested that each GP should encounter zero to
two cancer patients during the 10-day registration period. Power calculations in the
study protocol, based on estimates of the frequency of abdominal pain in general
practice in patients with and without cancer [11], suggested that about 11000
patients were needed in order to have power of 0.9 to detect differences between
cancer and non-cancer patients, with a significance level of 0.05. A sensitivity
analysis with a ’worst case’ scenario with smaller differences, suggested that
70000 patients could be needed.
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2.6. Statistical analyses
We estimated the associations between the GPs’ cancer suspicion and clinical
action with: subsequent cancer or not, new or recurrent cancer, sex, age and
countries. Where appropriate, analyses were restricted to new cases of cancer, or
new cases of abdominal cancer diagnosed within six months after consultation (per
protocol). Patients who had a stable or progressive cancer at the time of
consultation, or who developed pre-cancerous conditions, were excluded from
analyses.
Statistical analyses were performed using SPSS, version 22, and STATA, version
14. The chi-square test was used to examine differences between groups. Mantel-
Haentzel analysis was used to analyse gradients across groups. Multivariable
logistic regression models were applied to estimate associations between cancer
suspicion and incidence of cancer. We checked and found no interaction between
the independent variables in the models presented. Level of significance was 0.05.
2.7. Ethics
The Regional Committee for Medical and Health Research Ethics of Northern
Norway approved the survey protocol (Ref 2010/1056-4). Ethical approval was
thereafter given also in the other five participating countries. No patients were
contacted. Only the individual GP knew the identity of the patient.




Completed questionnaires from 67809 consecutive consultations were received
from 493 GPs (84% of those invited, 33–191 from each country). After corrections
for multiple consultations, 61802 patients were included in the cohort. Follow-up
forms on 707 cancer patients were received from 315 GPs, 640 of whom were
matched to a prior patient registration. After exclusions, 511 cancer patients (0.8%
of all patients in the study) were included (Fig. 1): 441 patients had a new cancer
diagnosis, and 70 patients had a recurrent cancer.
Among patients with new cancer, 251 (57%) had abdominal and 190 (43%) non-
abdominal cancer. For recurrent cases, these figures were 43 (61%) and 27 (39%),
respectively. A previous cancer was noted for 9.7% of symptomatic patients
subsequently diagnosed with new cancer, and for 8.3% without cancer.
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The median time to diagnosis for the 441 patients with a new cancer was 101 days,
mean 118 days.
Sex and age of the patients are shown in Table 1. Patients aged 75 years or over
constituted 17% of all patients and 42% of cancer patients.
3.2. Reported symptoms
Abdominal symptoms were recorded in 6264 patients (10.1%) (Fig. 2, Table 2). Of
these, 307 (0.5%) were diagnosed with a new cancer within the next six months:
with 175 (0.3%) being a new abdominal cancer (Fig. 1). Table 2 shows number of
symptoms for all 511 included cancer patients, including those diagnosed more
than six months after their consultation. For 10% of patients, this interval was more
than 8 months, with a maximum of 11 months. The proportion of symptomatic
[(Fig._1)TD$FIG]
Fig. 1. Inclusion and exclusion of patients with cancer.
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patients who were diagnosed with a subsequent cancer did not differ between
countries.
Abdominal symptoms were recorded in 100 (34%) of the 294 abdominal cancer
patients and in 29 (13%) of the 217 non-abdominal cancer patients (P < 0.001).
There was no statistical difference between male or female patients with cancer, or
between new and recurrent cancer. PPV for any cancer given any abdominal
symptom was 2.1%. Combinations of symptoms were more frequent in abdominal
Table 1. Number of patients: all patients, patients with symptoms and patients diagnosed with cancer after
consultation, by sex and different age groups. Mean/median age.
Age in years 16–29 % 30–54 % 55–74 % ≥75 % Total Mean age Median age Range 25–75 percentile
All patients 8457 14 23144 37 19983 32 10218 17 61802 53 54 16–102 38–68
Males 2931 12 8365 35 8689 36 3943 17 23928 55 56 16–102 41–69
Females 5526 15 14779 39 11294 30 6275 16 37874 53 52 16–101 37–68
Patients with symptoms 907 14 2261 36 1992 32 1104 18 6264 54 54 16–100 38–70
Males 236 11 767 35 792 36 401 18 2196 56 57 16–100 42–70
Females 671 16 1494 37 1200 30 703 17 4068 53 52 16–100 36–69
Patients with cancer 2 1 71 14 221 43 217 42 511 69 71 28–96 60–79
Males 0 0 26 11 104 46 101 43 231 70 72 35–94 62–79
Females 2 1 45 16 117 42 116 41 280 69 70 28–96 59–80
[(Fig._2)TD$FIG]
Fig. 2. Distribution of abdominal and general symptoms in 23928 male and 37874 female patients
consulting in primary care.
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Table 2. Number of abdominal and general symptoms in different patient groups, and positive predictive value (PPV) as an estimate of cancer risk in case of
at least one abdominal symptom.
All patients (N = 61802) Sum Males (N = 23928) Sum Females (N = 37874) Sum New cancer (N = 441) Recurrent cancer (N
= 70)


























45 2.1 2053 2098 23 3.1 722 745 22 1.6 1331 1353 34 8 2 1
Abdominal pain, lower
part
37 1.7 2101 2138 17 2.5 658 675 20 1.4 1443 1463 25 8 3 1
Constipation 22 3.1 679 701 10 4.6 208 218 12 2.5 471 483 19 2 1 0
Diarrhea 16 1.4 1107 1123 7 1.6 429 436 9 1.3 678 687 9 4 3 0
Distended abdomen,
bloating
27 2.6 1016 1043 14 3.8 353 367 13 1.9 663 676 21 4 2 0
Increased belching, flat-
ulence
17 3.4 489 506 12 6.4 176 188 5 1.6 313 318 11 4 2 0
Acid regurgitation 14 2.0 673 687 7 2.9 235 242 7 1.6 438 445 12 1 1 0
Rectal bleeding 18 4.4 387 405 4 2.6 147 151 14 5.5 240 254 16 0 1 1
Unexpected genital blee-
dinga
4 2.0 195 199 0 12 12 4 2.1 183 187 3 0 1 0
Haematuria, macroscop-
ic
7 4.7 143 150 5 6.1 77 82 2 2.9 66 68 7 0 0 0
Increased urinary fre-
quency
14 1.9 737 751 9 3.6 244 253 5 1.0 493 498 12 2 0 0
Other abdominal pro-
blems
34 2.9 1123 1157 20 4.8 397 417 14 1.9 726 740 20 7 3 4








































All patients (N = 61802) Sum Males (N = 23928) Sum Females (N = 37874) Sum New cancer (N = 441) Recurrent cancer (N
= 70)






















N = 251 N = 190 N = 43 N = 27
More than one abdomi-
nal symptom















89 (35.5%) 24 (12.6%) 11
(25.6%)
5 (18.5%)
No symptom 382 55156 55538 168 21564 21732 214 33592 33806 161 167 32 22
General symptoms (given at least one abdominal symptom)
Lack of appetite 26 2.9 863 889 10 3.1 315 325 16 2.8 548 564 19 2 4 1
Unusual tiredness 25 3.0 821 846 10 3.8 256 266 15 2.6 565 580 18 3 4 0
Involuntary weight loss 18 5.5 311 329 8 6.5 115 123 10 4.9 196 206 12 4 2 0
More than one general
symptom
19 4.6 390 409 7 4.9 136 143 12 4.5 254 266 14 1 4 0
Any general symptomd 43 (8.4%) 2.8 1514 1557
(2.5%)
17 3.2 512 529
(2.2%)
26 (9.3%) 2.5 1002 1028
(2.7%)
30 (12.0%) 7 (3.7%) 5 (11.6%) 1 (3.7%)
N=Number of patients.
a84 of the 187 females, including the four cancer patients, were postmenopausal.
bPercentage of all patients in the study, or of all males or all females.
cPercentages for symptoms are in relation to all patients, or all males or all females, who presented at least one abdominal symptom, and hence corresponds to the positive predictive value (PPV) for
any cancer.






































than in non-abdominal cancer (P < 0.001). The frequency of abdominal symptoms
did not differ significantly between patients with non-abdominal cancer and
patients without cancer.
Among patients with abdominal symptoms, 1557 (25%) also had general
symptoms. Among patients with a subsequent cancer diagnosis this figure was
33%: 35% in patients with abdominal cancer, and 28% for non-abdominal cancer (P
= 0.67).
3.3. Cancer suspicion in symptomatic patients, and relationship
with cancer
The GP’s cancer suspicion was raised for 1980 (31.6%) of patients with abdominal
symptoms (Table 3), 782 male and 1198 female: in 29.1% of patients this was
based on symptoms, in 16.5% based on clinical findings, and in 17.5% based on the
GP’s intuition; there was considerable overlap. In most cases, suspicion was slight.
“Strong” cancer suspicion was relatively less frequent for symptom-based
suspicion than for suspicion based on intuition (P < 0.001), or on clinical findings
(P = 0.007).
Cancer suspicion was higher for patients who had a subsequent cancer diagnosis (P
< 0.001). For symptom based suspicion, a suspicion was noted for 76 (58.9%) of
cancer patients versus 1742 (28.4%) of patients with no subsequent cancer. Any
suspicion was present for 65.9% vs. 30.9%, respectively. In 24.8% of subsequent
cancer cases, the GP noted no suspicion at the time of consultation.
Differences between countries were modest. GPs in Sweden (40.1%) and Norway
(35.3%) tended to have cancer suspicion in a higher proportion of their patients
than GPs in the other countries.
A logistic regression analysis based on patients with symptoms, with cancer or no
cancer as the dependent variable (Table 4), showed significant associations with
suspicion based on intuition and for increasing patient age, for all subgroups
analysed. For all new cancers, male sex was also associated with cancer. A
sensitivity analysis with all missing cases set to ‘no suspicion’ did not change
conclusions. There was an interaction between symptom-based and intuition-based
suspicion in the crude analyses, but the effect disappeared when adjusted for age.
In these analyses of these two kinds of cancer suspicion, OR for intuition in
relation to cancer was highest when there was no symptom-based suspicion (OR
3.94, 95% CI 1.45–10.71) (Table 4), and OR for symptom based suspicion was
highest when there was no intuition based suspicion (OR 1.82, 0.97–3.40, not
shown in table).
In order to assess the effect of possible variation in GP symptom recording,
conditional logistic regression was performed with statistical stratification for the
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Table 3. General practitioners’ cancer suspiciona during consultation, based on symptoms, clinical findings and intuition.
Cancer suspicion N Slight %b Medium %b Strong %b Positive suspicion %c Not at all %c Missing %c
Symptoms suggest cancer
Subsequent cancer or not Cancer 129 29 38.2 28 36.8 19 25 76 58.9 39 30.2 14 10.9
Not cancer 6135 1303 74.8 281 16.1 158 9.1 1742 28.4 3756 61.2 637 10.4
Clinical findings suggest cancer
Subsequent cancer or not Cancer 129 20 37.7 17 32.1 16 30.2 53 41.1 59 45.7 17 13.2
Not cancer 6135 710 72.3 153 15.6 119 12.1 982 16.0 4446 72.5 707 11.5
My intuitition suggests cancer
Subsequent cancer or not Cancer 129 23 35.9 19 29.7 22 34.4 64 49.6 49 38.0 16 12.4
Not cancer 6135 733 71 150 14.5 150 14.5 1033 16.9 4398 71.7 704 11.5
Any suspicion
Subsequent cancer or not Cancer 129 28 32.9 29 34.1 28 32.9 85 65.9 32 24.8 12 9.3
Not cancer 6135 1378 72.7 327 17.3 190 10 1,895 30.9 3,636 59.3 604 9.9
Country Norway 2501 669 75.7 130 14.7 85 9.6 884 35.3 1418 56.7 199 8.0
Denmark 1535 282 65.1 97 22.4 54 12.5 433 28.2 873 56.9 229 14.9
Sweden 583 153 65.4 49 20.9 32 13.7 234 40.1 332 57.0 17 2.9
Belgium 598 125 74.4 31 18.5 12 7.1 168 28.1 406 67.9 24 4.0
Netherlands 556 92 69.7 22 16.7 18 13.6 132 23.7 350 62.9 74 13.3
Scotland 491 85 65.9 27 20.9 17 13.2 129 26.3 289 58.9 73 14.9
Sum 6264 1406 71 356 18 218 11 1980 31.6 3668 58.6 616 9.8
Number of patients, by subsequent cancer or not, and by country. 6264 patients with at least one abdominal symptom. N=Number of patients.
aCancer suspicion was reported only for patients who presented symptoms.
bPer cent of Positive suspicion (Slight + Medium + Strong = 100%).






































Table 4. GPs' cancer suspicion in a mutually adjusted logistic regression model for cancer or not following
a consultation with recording of at least one abdominal symptom, analysed for all new cancer (N = 441), all
new abdominal cancer, diagnosed within 6 months (N = 175), and for recurrent cancer (N = 70).
Patients with cancer
Positive suspicion Not at all suspicion Crude OR Adjusted OR P value 95% CI
All New cancer (N in adjusted analysis = 5471)
Symptoms suggest cancer 69 34 4.40 1.49 0.193 0.82–2.71
Clinical findings suggest cancer 45 53 3.89 1.19 0.548 0.68–2.09
My intitution suggests cancer 55 45 5.26 2.11 0.016 1.15–3.89
sex (female = 0, male = 1) 1.71 0.010 1.14–2.56
age at consultation, in years 1.03 0.000 1.02–1.05
All New Abdominal cancer, diagnosed within 6 months (N in adjusted analysis = 5437)
Symptoms suggest cancer 53 15 7.66 1.81 0.158 0.79–4.09
Clinical findings suggest cancer 36 28 5.89 1.21 0.574 0.63–2.33
My intitution suggests cancer 45 20 9.69 3.62 0.001 1.65–7.93
sex (female = 0, male = 1) 1.39 0.200 0.84–2.29
age at consultation, in years 1.03 0.000 1.02–1.05
Recurrent cancer (N in adjusted analysis = 5385)
Symptoms suggest cancer 7 5 3.03 0.36 0.243 0.61–2.03
Clinical findings suggest cancer 8 6 6.11 1.36 0.704 0.28–6.72
My intitution suggests cancer 9 4 9.69 8.89 0.017 1.49–53.02
sex (female = 0, male = 1) 1.05 0.929 0.33–3.36
age at consultation, in years 1.01 0.026 1.00–1.00
Subgroup analysis, All New cancera (N in adjusted analysis = 1764)
A. When ‘Symptoms suggest cancer' = Yes
My intitution suggests cancer 50 16 2.59 2.12 0.012 1.18–3.79
sex (female = 0, male = 1) 1.52 0.099 0.92–2.49
age at consultation, in years 1.02 0.009 1.01–1.04
B. When ‘Symptoms suggest cancer' = Not at all (N in adjusted analysis = 3723)
My intitution suggests cancer 5 29 7.68 3.94 0.007 1.45–10.71
sex (female = 0, male = 1) 2.15 0.029 1.08–4.26
age at consultation, in years 1.06 <0.001 1.03–1.08
OR = odds ratio, N = Number of patients. Model adjusted by sex, age at consultation and cancer suspicion. Excluded from these
analyses: The 129 patients excluded as cancer patients because not new or recurrent cancer, cfr Fig. 1.
A corresponding subgroup analysis for ‘All new abdominal cancer, diagnosed within 6 months’, gave similar results, with sex not
significant in Model B. ORs were a little higher.
a‘Clinical findings suggest cancer' has been omitted from this analysis. If included, OR changes only slightly.
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different countries, and a separate stratification for individual GPs. Both gave only
minimal changes in ORs.
3.4. Diagnostic actions performed by GPs, symptomatic patients
Laboratory tests were performed for 45.4% of patients with abdominal symptoms.
Imaging was ordered for 10.4%, and referral or hospitalisation was undertaken for
20.0%. For 26.4% of patients a follow-up appointment in general practice was
arranged. None of these four options were used for 24.3% of patients (Table 5).
Combinations of actions are shown in Table 6.
Subsequent cancer patients had more of all three categories of investigation (P <
0.001) (Table 5). Follow-up appointment with the GP did not differ for cancer and
non-cancer patients. The frequency of each category of investigation, and follow-
up appointment with the GP, increased with increasing age group, but for
laboratory tests this gradient was not significant (P = 0.08). X-ray/imaging and
referral/hospitalization were used relatively more for patients 55–74 years and
relatively less for patients 16–29 years (P < 0.001). There were no differences
between men and women in relation to actions performed (data not shown).
There were clear differences between countries in actions taken for patients with
abdominal symptoms (Table 5). In Sweden, 11.8% of patients had no such further
diagnostic action, compared to 45.3% of patients in Belgium and 33.2% in
Scotland. Swedish GPs arranged more follow-up appointments in their own
practice but referred less frequently. Danish GPs referred most frequently.
Scandinavian GPs ordered more laboratory tests than GPs in the other countries (P
< 0.001 for all these differences).
4. Discussion
4.1. The basis for cancer suspicion, and the importance of
abdominal symptoms
Abdominal symptoms were common (10.1% of patients) and elicited cancer
suspicion in more patients than did clinical findings and intuition. However,
intuition based cancer suspicion was most strongly associated with subsequent
cancer. We think these results suggest that, while symptoms give the GP a basis to
consider a possible cancer, the complete clinical picture and the GP’s experience
and clinical competence [12] are necessary to guide further action. In clinical work,
GPs should pay attention to the important role of clinically justified intuition and
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Table 5. Further diagnostic action by GPs, by cancer and non cancer group and by countries. 6264 patients with at least one abdominal symptoms.











Lab test + Follow up with GP (N
= 685)
Lab test + Referral/Hospitalisation(N
= 339)
Cancer or not N N % N % N % N % N % N % N %
Cancer 129 67 51.9 26 20.2 52 40.3 41 31.8 16 12.4 14 10.9 12 9.3
Not cancer 6135 2778 45.3 627 10.2 1200 19.6 1613 26.3 1505 24.6 671 10.9 327 5.3
Country
Norway 2501 1401 56.0 287 11.5 470 18.8 605 24.2 484 19.3 261 10.4 188 7.5
Denmark 1535 613 39.9 103 6.7 398 25.9 405 26.4 378 25.0 201 13.1 78 5.1
Sweden 583 394 67.6 90 15.4 92 15.8 231 39.6 69 11.8 123 21.1 34 5.8
Belgium 598 148 24.7 55 9.2 104 17.4 120 20.1 271 45.3 26 4.3 17 2.8
Netherland 556 139 25.0 78 14.0 111 20.0 152 27.3 156 28.1 28 5 8 1.4
Scotland 491 150 30.5 40 8.1 77 15.7 141 28.7 163 33.2 46 9.4 14 2.9
Total 6264 2845 45.4 653 10.4 1252 20.0 1654 26.4 1521 24.3 685 10.9 339 5.4






































Table 6. Further diagnostic action by GPs. 6264 patients with at least one abdominal symptom.
N %
Single actions Lab tests only 1350
X-ray/imaging 174
Referral/hospitalisation 698
Follow-up appointment with GP 643
Sum 2865 45.7
Combination of 2 actions Lab tests + X-ray/imaging 193
Lab tests + Referral/hospitalisation 339
Lab tests +Follow up appointment with GP 685
X-ray/imaging + Referral/hospitalisation 23
X-ray/imaging + Follow up appointment with GP 43
Referral/hospitalisation+ Follow up appointment with GP 44
Sum 1327 21.2
Combination of 3 actions Lab tests + X-ray/imaging + Referral/Hospitalisation 46
Lab tests + X-ray/imaging + Follow up appointment with GP 137
Lab tests + Referral/hospitalisation + Follow up appointment with GP 65
X-ray/imaging + Referral/hospitalisation + Follow up appointment with GP 7
Sum 255 4.1
All 4 actions Lab tests + X-ray/imaging + Referral/hospitalisation + Follow up appointment with GP 30 0.5
Sum, number of patients with actions recorded 4477 71.5
Patients with recordings that they had none of these actions 1521 24.3
Patients with missing data 266 4.2






































4.2. How the GP acted
Active investigative and/or referral strategies were more frequent for the
subsequent cancer patients than for the other patients: for example referrals and
imaging were performed twice as often for patients who turned out to have cancer.
No further investigation or follow-up for one fourth of the patients with abdominal
symptoms may seem like a relatively high proportion. A correlation has been
shown between GPs’ readiness to investigate symptoms indicative of cancer and
cancer survival [13].
Follow-up with the GP may represent a form of watchful waiting and safety
netting. The increasing use of such follow-up with older patient age could be
justified by the increasing multimorbidity and the increased cancer prevalence seen
in ageing patients. However, given the value of the watchful waiting strategy, it
was unexpected and may seem worrisome that follow-up with the GP was not
greater for cancer than for non-cancer patients. Nonetheless, given that there was
no cancer suspicion for one quarter of the subsequent cancer patients, it is perhaps
only moderately surprising.
Even in the countries with the lowest rates of supplementary investigations, the
number of actions performed may seem high in relation to finding 511 cancer
patients. However, testing has more aims than diagnosing cancer, and it may be
seen as encouraging that modern GPs have at their disposal many practical tests
with discriminatory power in relation to cancer and other important diseases. The
differences between countries may be related to the level of cancer suspicion, to
practice traditions and within-country norms, and the availability of testing and
referral. Possibly, blood testing and other laboratory analyses are more readily
available in Nordic surgeries as point-of-care-tests. GPs’ readiness to make
subsequent appointments may vary with GP availability and workload. All GPs
know the difficult balance between acting appropriately when needed, and
avoiding unnecessary actions and cost. Possible actions in unclear clinical
situations range from fast track referral to watchful waiting, and GPs try hard to
find the best solution for individual patients.
4.3. Discussion within the context of the literature
Failure to appropriately suspect cancer may result from an insufficient medical
history, lack of a focused clinical examination, inappropriate supplementary
testing or follow-up of positive tests [1], but also from lack of consideration of
contextual data related to the patient and the patient environment [12]. A well-
recognised doctor’s cognitive fallacy is to stop gathering new data after reaching
a diagnosis and thus neglecting other possibilities, or to make symptoms fit a
prototypical context or frame, missing atypical variants [14]. The GPs’ reporting
of intuition as an important basis for suspecting cancer, may be rooted in an
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interaction between analytic and non-analytic processes during diagnostic work
[15]. Such dual reasoning strategies have been shown to help diagnosticians
overcoming misleading information [16]. Patient discourse may be vague and
does not always help the GP identify a chief complaint [17], although in our
study symptoms had been recorded when there was cancer suspicion. GPs
interviewed about how the thought of cancer arises in a consultation, discussed
‘intuitive knowing’ as a tacit feeling of alarm which could be difficult to
verbalise, but nevertheless was helpful. Such intuition is built on basic
knowledge, experience, and personal awareness [18]. We think such observations
de-mystify intuition and give it a natural place in the diagnostic reasoning of GPs.
Previous cases, the GP’s relationship with this particular patient, and cultural
factors are some of the elements throwing light on how the patient presents an
illness and how the GP interprets. Clinical observations rather than vague
impressions may be the basis for “gut feeling” [19, 20], this was neither apparent
nor contradicted in our study.
No cancer suspicion for approximately one quarter of the subsequent cancer
patients is similar to findings in a study of more general warning signs of cancer
[21]. All the symptoms investigated are common, and they may have been vague or
atypical in relation to cancer. The finding demonstrates that a GP must be willing
to revise diagnostic thinking regarding a symptomatic patient on subsequent
consultations.
We cannot assume that all cross-sectionally recorded symptoms were related to a
subsequent cancer. In an earlier study based on medical records, a probable
relationship between a ‘warning signal’ symptom and subsequent cancer was found
in 17 of 20 patients with such symptoms [22]. Abdominal symptoms may or may
not trigger cancer suspicion, and the GP’s intuition may agree with or overrule
what the symptom seems to suggest. Also, during an illness episode, symptoms as
well as clinical signs and intuition may change with time.
We have not found other articles documenting examination and referral strategies
when symptoms are presented to GPs. Patients typically express a preference for
diagnostic testing even at relatively low risk levels [23].
Abdominal symptoms presented in general practice require the same degree of
attention as classical alarm symptoms [24, 25]. Because all such symptoms are
unspecific and many are vague, the GP must gather further information for a
rational follow-up and safety-netting in cancer detection [26, 27]. In our abdominal
cancer patients, symptoms were recorded in only one third of the individuals.
Cancer can initially present in many ways, and no single symptom has close to a
100% sensitivity to any form of cancer. In our case, symptom registration was
limited to one discrete time during the progression of the not yet diagnosed disease.
Fortunately, many components of the diagnostic process contribute constructively
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to cancer suspicion [25]: clinical findings, supplementary testing, and as shown
here, GP intuition.
GPs contribute to modern cancer detection guidelines [28] and are able to provide
important triage and follow-up of patients, of large value to patients and society
[29].
4.4. Strength and limitations of the study
The prospective nature of the study ensured that neither the patient nor the GP
knew about the cancer diagnosis at the time of symptom registration. This
eliminates some of the bias inherent in observational retrospective and case-control
studies. However, data from one consultation that may become part of an illness
episode with a continuous pathway, will only be a point estimate of the GP’s
suspicion of cancer and inevitably underestimate the amount of symptom
information and actions gathering with time until diagnosis. Continuity over time
is an important aspect of general practice and implies repeated gathering and
patient-doctor discussion of new information. The information presented in this
article is limited to the two cross-sectional registrations, at Time 1 and Time 2.
Consecutive patients with face-to-face consultations were registered, with no
selection bias. The detailed instructions supported consistent data recording across
study sites, optimizing data quality. However, the GPs knew they were
participating in a study about cancer diagnosis, and this may have made them
more likely to suspect cancer and perform supplementary tests.
An important aspect of data validity is to what extent the GPs recorded all patients
where the reason for consultation was related to abdominal symptoms, or only
where the GP found an abdominal problem relevant. The GPs were instructed to
record all instances where symptoms were presented by the patient, either on the
patient’s own initiative or if it arose during the consultation. The minimal changes
in ORs for cancer suspicion when a conditional logistic regression analysis was
performed with stratification on countries and on GPs, suggest that accounting for
differences in the GPs’ symptom registration did not affect conclusions.
Cancer patients are haphazardly distributed among GPs, but some cancer patients
may have been missed when the GPs searched their records. Therefore, cancer
patients in the cohort are similar to but hardly representative of all cancer in these
countries
Combining data from six countries with different health systems has its limitations
and advantages. Our study benefits from a large sample size, and data reliability
increases if country differences seem reasonable in relation to differences in the
organisation of primary care. We find many similarities in the nature of general
practice consultations across the six included countries, even if the respective
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health systems may introduce some country-specific limitations in follow-up and
referral procedures [3, 8]. Documented variation may inspire re-thinking of one’s
own routines.
4.5. Implications for policy, practice and research
GPs initially may consider cancer located in the abdomen when abdominal
symptoms spur a cancer suspicion. Abdominal symptoms do not seem to increase
the possibility of non-abdominal cancer. However, this remains a challenge in
general practice: to have in mind the unusual, especially when it is of high clinical
importance. Therefore, in unclear cases, non-abdominal cancer sites should remain
a relevant consideration during diagnostic work-up. In general, our study adds
weight to the concept that GPs should have confidence in their traditional way of
working with patients, combining evidence from clinical epidemiology and
qualitative studies with tacit, experience based knowledge as a basis for listening
and communicating in order to understand patient ailments.
Studies of symptoms must primarily come from primary care settings. Review
articles about colorectal cancer from other settings hardly mention symptoms [30,
31]. Research data from the clinical setting in general practice provide important
complementary insights to hospital data, especially when it comes to understanding
the diagnostic pathway from first symptom to treatment of cancer. Our study adds
to this understanding. The study further demonstrates the feasibility of setting up
large studies in primary care in several countries, with benefits for study size and
for understanding of differences between countries.
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